Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCAPRICOR THERAPEUTICS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CAPRICOR THERAPEUTICS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
    Sep 17, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
    Aug 24, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    Aug 13, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13
    Aug 10, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
    Jul 30, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
    Jul 29, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
    Jul 27, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
    Jun 26, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
    Jun 26, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Capricor Therapeutics to Present at Upcoming Investor Conferences
    Jun 8, 2026Capricor Therapeutics, Inc. (CAPR) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$8.01Close · Oct 8, 2026